Evidence map›Paper›PMID 42529895›Full record

SynthesisNursing in critical care2026

Benefits and Risks of Intensive Glucose Control in Intensive Care Units: A Meta-Analysis of Randomized Controlled Trials.

Yuanjie Duan, Juan Liu, Shiyu Lin, Xi Li, Dan Luo, Lemei Zhu

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Nursing in critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuanjie DuanHunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University, Changsha, China.
Juan LiuHunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University, Changsha, China.ORCID https://orcid.org/0009-0005-5419-0764
Shiyu LinHunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University, Changsha, China.ORCID https://orcid.org/0009-0001-8350-7565
Xi LiHunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University, Changsha, China.
Dan LuoHunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University, Changsha, China.
Lemei ZhuHunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, School of Public Health, Changsha Medical University, Changsha, China.ORCID https://orcid.org/0000-0003-0477-3759

Funding

Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province, ChinaHunan province training program foundation of Changsha Medical University (Hunan Education Bureau Notice 2021 No. 29-26, Hunan Education Bureau Notice 2023 No. 318-26, Hunan Education Bureau Notice 2025 No. 26)Hunan Provincial Education Commission Foundation 23A0664Hunan Provincial Education Commission Foundation 24A0683Hunan Provincial Education Commission Foundation 24B0885Hunan Provincial Education Commission Foundation 25A0803Innovation and Entrepreneurship Education Base of Public Health and Preventive MedicineNational College Students' Innovative Entrepreneurial Training Plan Program S202410823019"The 14th Five-Year Plan" Application Characteristic Discipline of Hunan Province (Clinical Medicine)
6 · The paper itself

Abstract

backgroundHyperglycaemia is common among intensive care unit (ICU) patients and is associated with increased mortality. However, whether intensive or liberal glucose control is more beneficial remains controversial.

aimTo compare the benefits and risks of intensive versus liberal glucose control in ICU patients. STUDY

designA Meta analysis of randomized controlled trials.

methodsSystematic review and meta-analysis of randomized controlled trials (RCTs). We systematically searched PubMed, Cochrane Library, Embase and Web of Science from inception to October 30, 2024. The review was conducted according to PRISMA guidelines. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Data were independently screened and extracted by four reviewers. Relative risks (RRs) were pooled using a random effects model, and trial sequential analysis was performed for the primary outcome.

resultsSeventy RCTs were included, comprising 36 502 patients, of which 64 RCTs (32 491 patients, 89%) were conducted in adults and 6 RCTs (4011 patients, 11%) in children. The RR of all-cause mortality after intensive and liberal glucose control was 0.99 (95% CI, 0.93-1.05) in adults. Comparable findings were observed for all-cause mortality in children. Intensive glucose control had a statistically significantly higher risk of severe hypoglycaemia in both children (RR 5.70; 95% CI 2.60-12.51) and adults (RR 3.55; 95% CI 2.49-5.07). However, intensive glucose control had a statistically lower risk of infection in both children (RR 0.83; 95% CI 0.70-0.98) and adults (RR 0.78; 95% CI 0.63-0.97). In the subgroup analysis of adults, a lower risk of infection was observed in all surgical groups, but not in the medical group. There was no statistically significant difference in other complications, including sepsis, acute renal injury, new need for dialysis and need for blood transfusion.

conclusionsIntensive and liberal glucose control had similar effects on all-cause mortality in adults and children, though paediatric data are limited and should be interpreted cautiously. Intensive glucose control reduced infection risk, especially in surgical ICUs, but increased the risk of severe hypoglycaemia. RELEVANCE TO CLINICAL PRACTICE: These findings suggest that routine intensive glucose control does not improve survival and should be applied cautiously due to increased hypoglycaemia risk, although it may reduce infection risk, particularly in surgical ICU patients.

Indexed as

Blood GlucoseGlycemic ControlHyperglycemiaIntensive Care UnitsHumansHypoglycemiaRandomized Controlled Trials as TopicRisk AssessmentBlood Glucoseall‐cause mortalityintensive care unitintensive glucose controlliberal glucose control

Identifiers

PMID42529895
PMCPMC13420244

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.